Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04903119 |
Title | Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Peng Wang, MD PhD |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Markey Cancer Center | RECRUITING | Lexington | Kentucky | 40536 | United States | Details |
St. Luke's University Health Network | RECRUITING | Easton | Pennsylvania | 18045 | United States | Details |
Vanderbilt-Ingram Cancer Center | RECRUITING | Nashville | Tennessee | 37232 | United States | Details |